Mobile entertainment
-
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical ModelDetails
In a head-to-head diet-induced obese (DIO) mouse study,ASC47 low dose combination 1 (ASC47,3 mg/kg,subcutaneous (SQ),once every four weeks plus semaglutide,30 nmol/kg,SQ,once daily),demonstrated super
-
WiMi Develops FPGA-Based Digital Quantum Computer Verification TechnologyDetails
BEIJING,Dec. 18,2024-- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"),a leading global Hologram Augmented Reality ("AR") Technology provider,today anno
-
State Grid Ningxia Electric Power Co., Ltd. Guyuan Branch provides efficient services to help the relocation of the forest farmDetails
GUYUAN,China,Dec. 19,2024-- Recently,State Grid Ningxia Electric Power Co.,Ltd. Guyuan Branch has been highly praised by Sutai State-owned Forest Farm,Liupanshan Forestry Bureau,Guyuan City,Ningxia,fo
-
GienTech transforms enterprise software testing with the launch of a powerful AI-driven end-to-end solutionDetails
Next-generation Testing Center of Excellence (TCoE 3.0) integrates AI,ML,and automation to make enterprise software testing faster,more responsive and efficient
-
WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years CollectionDetails
Leading GreenCRDMO Driven by Innovation for a Healthier Future Offering End-to-end Green Biologics Solutions for the Entire Industry
-
CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet TherapyDetails
SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir
-
Fujitsu develops world's first multi-AI agent security technology to protect against vulnerabilities and new threatsDetails
Collaboration among AI agents specialized in security with skills andknowledges of attacks and protection
-
MGSD Announces Results for 2024 Fiscal YearDetails
NEW YORK,Dec. 13,2024-- Maitong Sunshine Cultural Development Co.,Ltd (OTCQB: MGSD),an enterprise that provides cultural tourism services and other related services and products,announced its financia
-
Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101Details
Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC)
-
Mining gold of music: eternal passion of Chinese 99-year-old conductorDetails
BEIJING,Dec. 13,2024-- A report from People\'s Daily: In July this year,the Shanghai Oriental Art Center (SHOAC) Citizens\' Concert celebrated its 18th anniversary. As the curtain rose,Chinese conduct